BackOryzon Genomics S.A. Overview

Oryzon Genomics S.A. Total Assets

Latest total assets for 0RDB.L: $140M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$140.61M
↑ 1.64% YoYΔ $2.26M vs prior year quarter

Peer trimmed avg / median

Loading

Oryzon Genomics S.A. Total Assets History

Loading

Oryzon Genomics S.A. vs. peers: Total Assets Comparison

Loading

Oryzon Genomics S.A. Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Oryzon Genomics S.A. (0RDB.L) FAQ

As of the most recent data (June 2026), 0RDB.L shows a total assets of $140M. That compares with $140M in the prior-year period — up 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 0RDB.L's total assets is now $140M (was $140M) — a 1.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Oryzon Genomics S.A. is outperforming or lagging.

Tracking 0RDB.L's total assets over time shows whether Oryzon Genomics S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $140M in the prior-year period — up 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Oryzon Genomics S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $140M) with ownership activity and broader fundamentals.

Oryzon Genomics S.A.'s total assets is $140M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.